| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2005;79:1563-1569
© 2005 The Society of Thoracic Surgeons
Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
Accepted for publication November 17, 2004.
* Address reprint requests to Dr van Domburg, Erasmus Medical Center, Thoraxcenter, Room H539, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands (E-mail: r.vandomburg{at}erasmusmc.nl).
BACKGROUND: Although several randomized controlled trials examined the relative benefits of coronary artery bypass graft (CABG) surgery and percutaneous coronary intervention (PCI), the most appropriate treatment remains a matter of debate, at least in some subsets of patients. Therefore, we evaluated the 8-year outcome after multivessel stent implantation (stent group) or coronary artery bypass surgery (CABG group) in a single-center propensity-matched cohort study.
METHODS: The stent study population consisted of all 409 consecutive patients who underwent an elective coronary intervention between 1995 and 1999 in whom at least 2 stents were implanted in multiple vessels. They were matched by using the propensity score method with 409 CABG patients of 1,723 CABG patients with multivessel disease who underwent elective CABG in the same period of time. The two populations were very different before matching. After matching, the CABG population resembled a stent population.
RESULTS: The cumulative survival rates after stent were 93%, 90%, and 82% at, respectively, 3, 5, and 8 years; and after CABG 97%, 93%, and 87% (p = 0.02). This was caused mainly by patients with left main disease (p = 0.03). Event-free survival was only 70%, 68%, and 64% after stent and 89%, 82%, and 78% after CABG at, respectively, 3, 5, and 8 years (p < 0.0001). After adjusting, stent was an independent predictor of higher mortality.
CONCLUSIONS: In this matched cohort study with an 8-year follow-up, survival was better and less repeat revascularizations were needed among patients undergoing elective CABG for the treatment of multivessel disease as compared with the stent group.
This article has been cited by other articles:
|
|
 |
|
  O. Soran, A. Manchanda, and S. Schueler Percutaneous coronary intervention versus coronary artery bypass surgery in multivessel disease: a current perspective Interactive CardioVascular and Thoracic Surgery, June 1, 2009; 8(6): 666 - 671. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Yi, Y.-N. Youn, K.-J. Yoo, and Y.-S. Hong Comparison of Off-pump Coronary Artery Bypass Grafting With Percutaneous Coronary Intervention Versus Drug-Eluting Stents for Three-Vessel Coronary Artery Disease Ann. Thorac. Surg., November 1, 2008; 86(5): 1438 - 1443. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Rastan, E. Boudriot, V. Falk, A. P. Kappetein, M. A. Borger, P. W. Serruys, G. Schuler, and F. W. Mohr Frequency and pattern of de-novo three-vessel and left main coronary artery disease; insights from single center enrolment in the SYNTAX study Eur. J. Cardiothorac. Surg., August 1, 2008; 34(2): 376 - 383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kohsaka, M. Goto, S. Virani, V.-V. Lee, N. Aoki, M. A. Elayda, R. M. Reul, and J. M. Wilson Long-term clinical outcome of coronary artery stenting or coronary artery bypass grafting in patients with multiple-vessel disease. J. Thorac. Cardiovasc. Surg., August 1, 2008; 136(2): 500 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Yang, H.-C. Gwon, S. J. Cho, J. Y. Hahn, J.-H. Choi, S. H. Choi, Y. T. Lee, S. H. Lee, K. P. Hong, and J. E. Park Comparison of Coronary Artery Bypass Grafting With Drug-Eluting Stent Implantation for the Treatment of Multivessel Coronary Artery Disease Ann. Thorac. Surg., January 1, 2008; 85(1): 65 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. C. Austin Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement. J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1128 - 1135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. Bair, J. B. Muhlestein, H. T. May, K. G. Meredith, B. D. Horne, R. R. Pearson, Q. Li, K. R. Jensen, J. L. Anderson, and D. L. Lappe Surgical Revascularization Is Associated With Improved Long-Term Outcomes Compared With Percutaneous Stenting in Most Subgroups of Patients With Multivessel Coronary Artery Disease: Results From the Intermountain Heart Registry Circulation, September 11, 2007; 116(11_suppl): I-226 - I-231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H Wong, S. Wan, and M. J Underwood Myocardial Revascularization: Surgery or Stenting? Asian Cardiovasc Thorac Ann, June 1, 2007; 15(3): 264 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. Taggart Coronary Artery Bypass Grafting is Still the Best Treatment for Multivessel and Left Main Disease, But Patients Need to Know Ann. Thorac. Surg., December 1, 2006; 82(6): 1966 - 1975. [Full Text] [PDF]
|
|
|
|
|
|
G. Gao, Y. Wu, G. L. Grunkemeier, A. P. Furnary, and A. Starr Long-term survival of patients after coronary artery bypass graft surgery: comparison of the pre-stent and post-stent eras. Ann. Thorac. Surg., September 1, 2006; 82(3): 806 - 810. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. B. Barner Status of percutaneous coronary intervention and coronary artery bypass. Eur. J. Cardiothorac. Surg., September 1, 2006; 30(3): 419 - 424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. R. Osswald How to overcome difficulties in the evaluation of best possible decision-making in redo-revascularization? Eur. Heart J., February 2, 2006; 27(4): 375 - 376. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
